Revance Therapeutics Inc (RVNC) Shares Up Despite Recent Market Volatility
Revance Therapeutics Inc (NASDAQ: RVNC)’s stock price has increased by 5.11 compared to its previous closing price of 4.70. However, the company has seen a
Revance Therapeutics Inc (NASDAQ: RVNC)’s stock price has increased by 5.11 compared to its previous closing price of 4.70. However, the company has seen a
The 36-month beta value for RVNC is also noteworthy at 1.10. There are mixed opinions on the stock, with 6 analysts rating it as a
In the past week, RVNC stock has gone down by -3.31%, with a monthly gain of 6.35% and a quarterly plunge of -14.72%. The volatility
The stock has a 36-month beta value of 1.09. Opinions on the stock are mixed, with 6 analysts rating it as a “buy,” 1 as
The stock price of Revance Therapeutics Inc (NASDAQ: RVNC) has plunged by -0.70 when compared to previous closing price of 5.70, but the company has
In the past week, RVNC stock has gone down by -4.84%, with a monthly decline of -11.94% and a quarterly plunge of -28.87%. The volatility
while the 36-month beta value is 1.02. The public float for RVNC is 78.11M, and currently, short sellers hold a 16.19% ratio of that floaft.
Moreover, the 36-month beta value for RVNC is 1.00. The public float for RVNC is 78.30M and currently, short sellers hold a 18.91% of that
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.